Mild Stroke and Rapidly Improving Symptoms-Reference-Cited by-同舟云学术

Mild Stroke and Rapidly Improving Symptoms

Published:2011-11 Issue:11 Volume:42 Page:3005-3007
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Balucani Clotilde¹,Levine Steven R.¹

Affiliation:

1. From the Stroke Center and Department of Neurology (C.B., S.R.L.), State University of New York Downstate Medical Center, Brooklyn, and Department of Neurology (C.B.), University of Perugia, Perugia, Italy.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Link

https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.111.628701

Reference30 articles.

1. Tissue Plasminogen Activator for Acute Ischemic Stroke

2. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

3. Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator

4. Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

5. Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standard clinical and imaging-based small vessel disease parameters associated with mild stroke versus non-mild stroke;Journal of Central Nervous System Disease;2023-01-14

2. Reasons for Exclusion From Intravenous Thrombolysis in Acute Ischemic Stroke: Experience From a Moroccan Stroke Unit;Cureus;2023-01-02

3. Causas de no realización de trombólisis sistémica en pacientes ingresados a una unidad de ACV;Neurología Argentina;2021-01

4. Progression of stroke deficits in patients presenting with mild symptoms: The underlying etiology determines outcome;PLOS ONE;2020-04-24

5. Reperfusion therapy for minor stroke: A systematic review and meta‐analysis;Brain and Behavior;2019-09-18